Excellent project meeting at Bergamo

The consortium enjoyed a constructive meeting at the end of November, hosted by Prof Beppe Remuzzi and his team at the Insitute Mario Negri in Bergamo. Progress was reviewed, plans were refined and preparations for the next six months of collaboration were made.

The photo shows the consortium at the Institute Mario Negri.

Screenshot 2016-01-19 19.45.26

NEPHSTROM in the Media again

NEPHSTROM partner NHSBT received good coverage in the UK and international diabetes media in October.

Diabetes breakthrough: New stem cells that can halt kidney disease about to be tested
express.co.uk, 19 Oct 2015, UK, Keyword: NHS Blood and Transplant, Journalist: Jon Austin
Dr Eric Austin, head of Stem Cell Immunotherapy at the Advanced Therapy Unit within the Stem Cells and Immunotherapies department at NHS Blood and Transplant’s site in Speke, Liverpool, said: “This is an exciting project for us to be involved with – especially as the treatment has the potential to lead to life saving outcomes for a major illness.

Also reported in:Screenshot 2015-11-18 18.59.03

PA News Wire, 20 Oct 2015

The project also enjoyed coverage in

  • The Diabetes Times
  • Diabetes.co.uk
  • Diabetes Forum.com
  • StarMine News
  • PharmaTimes Digital

Looking forward to Bergamo

This month (November) sees the consortium assemble in Bergamo for our second plenary meeting (the first one since the kick-off in Dublin). The meeting is hosted by Beppe Remuzzi and his team at the Istituto Mario Negri (IRFMN). We look forward to catching up on all the news from the cell production centres, and to putting in place the facilities to carry out the clinical trial (led, of course, by IRFMN).


LMU Munich Press Release

LMUM distributed a press release about NEPHSTROM, aimed at the German-language press and public.

Screenshot 2015-07-01 10.18.54


The full text was as follows:

Neue Klinische Studie zur Stammzelltherapie bei diabetischer Nierenschädigung

24.06.2015 – Die Arbeitsgruppe um Prof. Hans-Joachim Anders am Nephrologischen Zentrum der Medizinischen Klinik und Poliklinik IV leitet ein Teilprojekt in dem EU-Projekt NEPHSTROM (Novel Stromal Cell Therapy for Diabetic Kidney Disease).

Präklinische Arbeiten und eine erste klinische Studie zur Stammzelltherapie bei diabetischer Nierenschädigung werden durch das Horizon-2020-Programm der Europäischen Union mit 6 Millionen Euro gefördert. Das auf vier Jahre ausgelegte Projekt wird die durch Forscher an der National University of Ireland in Galway (NUI Galway) entwickelte Stammzelltherapie auf ihre klinische Sicherheit und Wirksamkeit überprüfen.

Eine diabetische Nephropathie (DN) entwickeln 25 bis 40 Prozent aller Patienten mit Diabetes weltweit, häufig mit der Folge eines Nierenversagens und damit einer wesentlichen Todesursache bei Diabetes. “Wir hoffen, mit einer einmaligen intravenösen Injektion von Mesenchymalen Stammzellen den Verlauf der diabetischen Nierenschädigung günstig beeinflussen zu können”, sagt Prof. Anders, Oberarzt des Nephrologischen Zentrums am LMU-Klinikum.



Great further media coverage of NEPHSTROM

The launch of the NEPHSTROM project received further excellent coverage in the media, social media and EU vehicles. Coverage now includes all the following:

RTÉ Radio 1 News (RTE is the Irish national broadcaster)

8 June, at 7am and 8am 9am (during Morning Ireland) clips are 1 minute 30 seconds long



Screenshot 2015-06-23 14.59.40

RTÉ One News, 8 June




The Irish Times, 8 June


Screenshot 2015-06-23 14.57.22



The Irish Examiner, 8 June


Screenshot 2015-06-23 14.56.20



UTV Ireland online, 8 June


Screenshot 2015-06-23 14.55.34



The Journal.ie, 8 June


Screenshot 2015-06-23 14.54.56



The Irish Mirror


Screenshot 2015-06-23 14.54.04



Yahoo News


Screenshot 2015-06-23 14.52.21





Screenshot 2015-06-23 14.47.55




Connacht Tribune


Screenshot 2015-06-23 14.47.01






Screenshot 2015-06-23 14.45.59




www.newstalk.com (Newstalk Radio, an Irish nationwide radio station)


Screenshot 2015-06-23 14.44.47




EU news you can use – the newsletter of the EU Commission Representation in Ireland

Screenshot 2015-06-23 14.41.55

EU MSC2 2015: Contributing to MSC Knowledge-Sharing, Research & Development

Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC2 2015, a meeting in Leiden, NL on September 7th and 8th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden.

The objectives of the meeting are to:

  • Enhance knowledge-sharing between EU research groups working in the mesenchymal stromal cell biology domain
  • Engage with European Commission Project Officers and other stakeholders from International Society of Cellular Therapy, stem cell ethicists and the European Medicines Agency (EMA)
  • Assemble trans-disciplinary research groups working across the global health spectrum but with a common focus of mesenchymal stromal cell biology
  • Bring up-and-coming researchers together for networking purposes, and to explore future consortium building and international funding application opportunities


Expected impacts and outcomes:

  • Provide opportunities to develop new mesenchymal stromal cell networks
  • Disseminate the findings and challenges between MSC-focussed consortia
  • Improve the communication potential of research, outcomes and the value of the research
  • Explore potential for new commercial technologies
  • Collectively enhance the quality and impact of planned clinical trials

These EU projects are:

  • Boosting human capital: 20-30 positions created
  • Improving the quality of life for European citizens
  • Progressing the clinical translation of MSC research and developments


For more information, please visit EU MSC2 2015 and register via Eventbrite.

For queries: LeidenRM@gmail.com

Danielle Nicholson, Orbsen Therapeutics, NUI Galway and Brigitte Wieles, Project Manager LUMC